Quotazioni in diretta

HUGE FSD Pharma Inc

0,3283

0,0133 (4,22%)

18 Mag 2024 - Chiuso

Dati in Delay di 15 minuti

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

nullnull

Grafico Azioni FSD Pharma (NASDAQ:HUGE)
Storico
Da Apr 2024 a Mag 2024

Clicca qui per i Grafici di FSD Pharma

Grafico Azioni FSD Pharma (NASDAQ:HUGE)
Storico
Da Mag 2023 a Mag 2024

Clicca qui per i Grafici di FSD Pharma

Notizie FSD Pharma Inc - HUGE

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Giovedì 16 Maggio 2024 (2 giorni fa) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Martedì 20 Febbraio 2024 (3 mesi fa) • Edgar (US Regulatory)

GBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss Case
Giovedì 11 Gennaio 2024 (4 mesi fa) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Venerdì 5 Gennaio 2024 (4 mesi fa) • Edgar (US Regulatory)

InvestmentPitch Media Video Discusses FSD Pharma’s Continued Development of its Exciting New Rapid Detox Drink UNBUZZD™, with Video Comments from Kevin Harrington
Venerdì 22 Settembre 2023 (8 mesi fa) • GlobeNewswire Inc.

FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW)
Sabatp 26 Agosto 2023 (9 mesi fa) • Business Wire

InvestmentPitch Media Video Features FSD Pharma’s Definitive Agreement Granting Exclusive Rights for Launch of UNBUZZD, a Revolutionary Rapid Alcohol Detoxification Drink
Giovedì 3 Agosto 2023 (9 mesi fa) • GlobeNewswire Inc.

Arbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201
Lunedì 17 Luglio 2023 (10 mesi fa) • Business Wire

FSD Pharma Retains Christian Attar Law and Team of Experts to Lead Preliminary Investigation of Possible Naked Short Selling and Manipulation in its stock
Lunedì 10 Luglio 2023 (10 mesi fa) • Business Wire

FSD Pharma Appoints Zeeshan Saeed as Chief Executive Officer, Anthony Durkacz to Serve as Executive Co-Chairman of the Board of Directors
Martedì 4 Luglio 2023 (10 mesi fa) • Business Wire

FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders
Venerdì 30 Giugno 2023 (11 mesi fa) • Business Wire

InvestmentPitch Media Video Discusses FSD Pharma’s Granting of Exclusive Rights to Revolutionary Recreational Alcohol Misuse Technology to Celly Nutrition
Venerdì 23 Giugno 2023 (11 mesi fa) • GlobeNewswire Inc.

Più FSD Pharma Inc Articoli Notizie

Delta Israel Brands (PK)

KGL Resources (PK)

Landa APP 3 LLC 6696 Mab... (GM)

Heron Lake Bioenergy (GM)

Vontobel Financial Produ...

NLBNPIT217A5 20351221 5....

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea